kentucky glp-1 gi obstruction lawsuit gastrointestinal attorney Ozempic kentucky semaglutide gi obstruction law
Description
GLP-1RAG supports metabolic health by supporting the GLP-1 (glucagon-like peptide-1) pathway through active isolates and extracts that supports glucose metabolism, insulin sensitivity, and aids in appetite control.Promotes GLP-1 secretion and activity.

GLP-1 RAs have demonstrated benefits in coronary artery disease, heart failure, blood pressure, and atrial fibrillation irrespective of type 2 diabetes mellitus status, with new possible applications in peripheral arterial disease

Initially approved to treat diabetes, glucagon-like peptide-1 (GLP-1) drugs are being heralded to address obesity and, more recently, obstructive sleep apnea (OSA).

Rx only

Most patients in both groups had no significant gastric retention at the time of EGD
